Medtronic plc (MDT)
After hours:
| Previous close | 85.64 |
| Open | 85.83 |
| Bid | 86.10 x 1000 |
| Ask | 86.35 x 800 |
| Day's range | 85.10 - 86.17 |
| 52-week range | 68.84 - 91.00 |
| Volume | |
| Avg. volume | 6,106,742 |
| Market cap | 114.086B |
| Beta (5Y monthly) | 0.80 |
| PE ratio (TTM) | 27.28 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.76 (3.21%) |
| Ex-dividend date | 21 Mar 2024 |
| 1y target est | N/A |
- PR Newswire
Medtronic Affera™ Mapping and Ablation System with Sphere-9™ Catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatment
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced positive results demonstrating excellent safety and efficacy of the Affera™ Mapping and Ablation System with Sphere-9™ Catheter, an all-in-one pulsed field (PF) and radiofrequency (RF) ablation and high density (HD) mapping catheter for the treatment of persistent atrial fibrillation (AFib). The SPHERE Per-AF study, a U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) pivotal trial, c
- PR Newswire
Late-breaking data show reliable performance of small-diameter defibrillation lead, the Medtronic OmniaSecure™
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that its investigational OmniaSecure™ defibrillation lead met its primary safety and effectiveness endpoints, exceeding prespecified performance goals, in the global Lead Evaluation for Defibrillation and Reliability (LEADR) Pivotal Trial. Late breaking results were presented at Heart Rhythm 2024 and simultaneously published in the journal Heart Rhythm. Worldwide, the OmniaSecure defibrillation lead is investigational
- GlobeNewswire
Medtronic Recognized for Health Monitoring Innovation in 8th Annual MedTech Breakthrough Awards Program
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and CompaniesLOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market, today announced that Medtronic plc (NYSE: MDT), a global leader in healthcare technology, has been selected as winner of the “Best New Mo
